Huanxin Zhang
Xuzhou, 221002, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Immunomagnetic nanoprobe-mediated capture of circulating multiple myeloma cells for monitoring of proteasome inhibitor response.
Journal: IEEE transactions on nanobioscience
Published: July 20, 2026
Allo-HSCT Might Improve Long-Term Survival in Patients with CD56-Positive AML.
Journal: Journal of blood medicine
Published: February 08, 2026
Late phase transfusion after CAR T therapy is associated with persistent hematotoxicity and non-relapse mortality in multiple myeloma: a post hoc analysis.
Journal: BMC medicine
Published: February 07, 2026
Anti-BCMA/GPRC5D CAR T cells in patients with relapsed or refractory multiple myeloma who have extraosseous extramedullary disease.
Journal: Blood
Published: February 03, 2026
Publisher Correction: Single-cell and bulk transcriptomics uncovers PRKD2-driven tumor stemness and progression in multiple myeloma.
Journal: Scientific reports
Published: November 26, 2025
Construction and Validation of a Progression-Free Survival Prediction Model for Newly Diagnosed Multiple Myeloma Patients With 1q21 Gain/Amplification.
Journal: Cancer medicine
Published: October 09, 2025
Short-course high-dose cytarabine consolidation therapy before allogeneic hematopoietic stem cell transplantation improves 2-year relapse-free survival but not overall survival in patients with acute myeloid leukemia: a single-center retrospective study.
Journal: Annals of hematology
Published: September 06, 2025
Effect of cytoreductive chemotherapy on the incidence of differentiation syndrome in patients with newly diagnosed acute promyelocytic leukemia.
Journal: Chinese medical journal
Published: July 26, 2025
Nutritional status indices on the prognosis of patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy.
Journal: Frontiers in nutrition
Published: June 26, 2025
Effect of metachronous primary and secondary solid cancers in patients with multiple myeloma: a retrospective study from a single-center.
Journal: Frontiers in immunology
Published: October 24, 2024
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial.
Journal: The Lancet. Haematology
Published: March 10, 2024
Last Updated: 09/26/2026